Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

Abstract

To analyse the frequency and causes of treatment discontinuation in patients who were treated with an integrase strand transfer inhibitor (INSTI), with a focus on neuropsychiatric adverse events (NPAEs)

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Last time updated on 14/05/2020
    Last time updated on 07/06/2023
    Last time updated on 14/05/2020